This webinar features Dr. Nimira Alimohamed and Dr. Bernie Eigl, providing an in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
You’ll learn about the clinical trial data that led to its approval, gain a better understanding of the treatment process, and explore potential side effects. If you have questions about this new therapy, this is a great opportunity to get answers from experts in the field.